Patents by Inventor Do-Ha LEE

Do-Ha LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11484601
    Abstract: The present invention relates to a melittin-anticancer drug conjugate in which melittin and an anticancer drug are conjugated, and to a method of preparing a melittin-anticancer drug conjugate by connecting melittin and an anticancer drug. A conjugate of the present invention is an anticancer material for targeting M2-type tumor-associated macrophages (TAM) and exhibits an excellent effect of selectively selecting M2-type tumor-associated macrophages (TAM), and thus may be used for a use of drug delivery for targeting M2-type tumor-associated macrophages.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: November 1, 2022
    Assignee: TWINPIGBIOLAB INC.
    Inventors: Hyun-Su Bae, Chan-Ju Lee, Jin-Hyun Jeong, Do-Ha Lee, Jeong-Dong Kim
  • Publication number: 20210244823
    Abstract: The present invention relates to a melittin-anticancer drug conjugate in which melittin and an anticancer drug are conjugated, and to a method of preparing a melittin-anticancer drug conjugate by connecting melittin and an anticancer drug. A conjugate of the present invention is an anticancer material for targeting M2-type tumor-associated macrophages (TAM) and exhibits an excellent effect of selectively selecting M2-type tumor-associated macrophages (TAM), and thus may be used for a use of drug delivery for targeting M2-type tumor-associated macrophages.
    Type: Application
    Filed: May 7, 2019
    Publication date: August 12, 2021
    Applicant: TWINPIGBIOLAB INC.
    Inventors: Hyun-Su BAE, Chan-Ju LEE, Jin-Hyun JEONG, Do-Ha LEE, Jeong-Dong KIM